Total Payments
$15,260
2022 Payments
$2,250
Companies
8
Transactions
24
Medicare Patients
237
Medicare Billing
$46,499
Payment Breakdown by Category
Other$13,890 (91.0%)
Food & Beverage$1,059 (6.9%)
Travel$309.26 (2.0%)
Education$1.79 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,890 | 8 | 91.0% |
| Food and Beverage | $1,059 | 13 | 6.9% |
| Travel and Lodging | $309.26 | 2 | 2.0% |
| Education | $1.79 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $12,841 | 11 | $0 (2022) |
| Allergan, Inc. | $1,602 | 3 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $458.36 | 5 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $119.08 | 1 | $0 (2018) |
| Alkermes, Inc. | $94.24 | 1 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $81.94 | 1 | $0 (2019) |
| Neuronetics, Inc. | $46.18 | 1 | $0 (2018) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $17.33 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $2,250 | 1 | ABBVIE INC. ($2,250) |
| 2021 | $11,911 | 11 | AbbVie Inc. ($10,591) |
| 2020 | $200.00 | 1 | Allergan, Inc. ($200.00) |
| 2019 | $203.73 | 3 | Otsuka America Pharmaceutical, Inc. ($121.79) |
| 2018 | $379.50 | 4 | Otsuka America Pharmaceutical, Inc. ($120.00) |
| 2017 | $315.71 | 4 | Otsuka America Pharmaceutical, Inc. ($216.57) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/20/2022 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,760.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $64.60 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2021 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,760.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,080.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $197.26 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $112.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $82.59 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,320.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/27/2021 | Allergan, Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,320.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2020 | Allergan, Inc. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2019 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $81.94 | General |
| Category: NEUROSCIENCE | ||||||
| 01/08/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Education | In-kind items and services | $1.79 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2018 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $46.18 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 07/10/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $94.24 | General |
| Category: CNS | ||||||
| 05/15/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $119.08 | General |
| Category: CNS | ||||||
| 09/28/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $96.57 | General |
| Category: PSYCHIATRY | ||||||
| 07/24/2017 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $17.33 | General |
| 03/21/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/09/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $81.81 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 41 | 115 | $31,972 | $7,913 |
| 2022 | 4 | 82 | 211 | $59,414 | $16,090 |
| 2021 | 3 | 56 | 207 | $50,661 | $13,977 |
| 2020 | 3 | 58 | 168 | $31,348 | $8,519 |
Total Patients
237
Total Services
701
Medicare Billing
$46,499
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 54 | $17,820 | $4,348 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 61 | $14,152 | $3,565 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 65 | $21,450 | $5,163 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 78 | $18,096 | $5,098 | 28.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 27 | $12,447 | $3,709 | 29.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 15 | 41 | $7,421 | $2,119 | 28.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 136 | $31,552 | $8,271 | 26.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 42 | $13,860 | $4,142 | 29.9% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 13 | 29 | $5,249 | $1,564 | 29.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 120 | $23,280 | $5,153 | 22.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 26 | $4,086 | $2,199 | 53.8% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 14 | 22 | $3,982 | $1,166 | 29.3% |
About Dr. John Lipkin, M.D
Dr. John Lipkin, M.D is a Psychiatry healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235106980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Lipkin, M.D has received a total of $15,260 in payments from pharmaceutical and medical device companies, with $2,250 received in 2022. These payments were reported across 24 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,890).
As a Medicare-enrolled provider, Lipkin has provided services to 237 Medicare beneficiaries, totaling 701 services with total Medicare billing of $46,499. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Eugene, OR
- Active Since 03/01/2006
- Last Updated 03/15/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1235106980
Products in Payments
- VRAYLAR (Drug) $14,443
- ABILIFY MAINTENA (Drug) $336.57
- REXULTI (Drug) $121.79
- LATUDA (Drug) $119.08
- Aristada 441 mg (Drug) $94.24
- TRINTELLIX (Drug) $81.94
- NEUROSTAR TMS THERAPY (Device) $46.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Eugene
Dr. Hernan Schmidt, M.d, M.D
Psychiatry — Payments: $6,567
Psychiatry $6,567
Victor Richenstein, Md, MD
Psychiatry — Payments: $5,106
Psychiatry $5,106
Veronica Alfero, Md, MD
Psychiatry — Payments: $2,017
Psychiatry $2,017
Dr. Franc Strgar, M.d, M.D
Psychiatry — Payments: $1,445
Psychiatry $1,445
Dr. Russell Geoffrey, Md, MD
Psychiatry — Payments: $1,378
Psychiatry $1,378
Dr. Harold Whiteley, M.d, M.D
Psychiatry — Payments: $1,215
Psychiatry $1,215